Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Respiratory Care Professionals
Respiratory Care Professionals Respiratory Care Professionals

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest

Loading Events...

COPD burden in the 7MM to increase by 13.3% over the next decade, says GlobalData | NEWS-Line for Respiratory Care Professionals
 


COPD burden in the 7MM to increase by 13.3% over the next decade, says GlobalData


Source:

COPD burden in the 7MM to increase by 13.3% over the next decade, says GlobalData

The total prevalent cases of chronic obstructive pulmonary disease (COPD) in the seven major markets (7MM*) is expected to increase from 59.3 million cases in 2018 to 67.2 million in 2028, at an annual growth rate (AGR) of 1.33%, according to GlobalData, a leading data and analytics company.

The company’s latest report, ‘Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028,’ provides an overview of the risk factors and historical trends for COPD in the 7MM for people ages ≥35 years.

Of the 7MM, the US is expected to have the highest number of total prevalent cases, increasing from 26.6 million in 2018 to 31.1 million in 2028. There were 24.8 million cases in the 5EU* in 2018, while Japan had 7.9 million.

Bharti Prabhakar, Senior Epidemiologist at GlobalData, says: “The major drivers for the upward trend in the total prevalent cases of COPD in the 7MM over the next decade is attributable to the underlying population demographics, as well as an increase in the exposure to risk factors such as smoking.”

COPD usually starts after 30 years of age, and can have a major impact on patient health-related quality of life and work productivity. There is an unmet need for epidemiological studies to better understand the quality of life of people living with the condition.

Bharti concludes: “COPD is associated with debilitating long-term effects, and is largely irreversible, even with treatment. In addition to accurately diagnosing and treating COPD, understanding the risk factors and comorbidities of the disease can help improve patients’ quality of life.”

*7MM = US, France, Germany, Italy, Spain, UK and Japan

*5EU = France, Germany, Italy, Spain and UK

For more information

Email: [email protected]

Comments provided by Bharti Prabhakar, Senior Epidemiologist of Epidemiology division at GlobalData

Information based on GlobalData’s report: Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028

This press release is written using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts

About GlobalData

4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.







Share This!



Loading Jobs...
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.